Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 478

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Osteoporosis and Inflammation

Open access
Mundy, Gregory R.·2008·Nutrition Reviews

Abstract

Osteoporosis represents a major healthcare burden, affecting approximately 10 million people aged over 50 years in the United States and with another 30 million or more at risk. One of the major contributing factors to osteoporosis is withdrawal of estrogen during menopause in women. Human and animal experiments have implicated pro-inflammatory cytokines as primary mediators of the accelerated bone loss at menopause including interleukin-1, tumor necrosis factor-alpha, and interleukin-6. Increased production of pro-inflammatory cytokines is associated with osteoclastic bone resorption in a number of disease states including rheumatoid arthritis, periodontitis, and multiple myeloma; estrogen withdrawal is associated with increased production of pro-inflammatory cytokines, and exposure of bone cultures to supernatants from activated leukocytes is associated with increased bone resorption. A major advance has been the discovery of RANKL, its receptor RANK, and the endogenous inhibitor osteoprotegerin. The binding of RANKL to RANK is essential for the differentiation and activation of osteoclasts and mediates the actions of essentially all known stimulators of osteoclastic bone resorption. RANKL expression is heightened in post- compared with pre-menopausal women, and this effect is attenuated by estrogen replacement therapy. RANKL is also a therapeutic target; a human antibody with high specificity and affinity to RANKL is currently under clinical evaluation for the treatment of osteoporosis in post-menopausal women and of metastatic bone disease in cancer patients with bone metastasis. Early data are promising.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1753-4887.2007.tb00353.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 43

  1. 2004, Bone Health and Osteoporosis: A Report of the Surgeon General
  2. Gass, 2006, Preventing osteoporosis-related fractures: an overview, Am J Med, 119, 3, 10.1016/j.amjmed.2005.12.017 · DOI · Paper page
  3. Anderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001/jama.291.14.1701 · DOI · Paper page
  4. Curb, 2006, Venous thrombosis and conjugated equine estrogen in women without a uterus, Arch Intern Med, 166, 772, 10.1001/archinte.166.7.772 · DOI · Paper page
  5. Shumaker, 2004, Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study, JAMA, 291, 2947, 10.1001/jama.291.24.2947 · DOI · Paper page
  6. Caputo, 1976, Failure of estrogens and androgens to inhibit bone resorption in tissue culture, Endocrinology, 98, 1065, 10.1210/endo-98-4-1065 · DOI
  7. Reddy, 1998, Control of osteoclast differentiation, Crit Rev Eukaryot Gene Expr, 8, 1, 10.1615/CritRevEukarGeneExpr.v8.i1.10 · DOI
  8. Boyce, 1989, Effects of interleukin-1 on bone turnover in normal mice, Endocrinology, 125, 1142, 10.1210/endo-125-3-1142 · DOI · Paper page
  9. Dewhirst, 1985, Purification and partial sequence of human osteo-clast-activating factor: identity with interleukin 1 beta, J Immunol, 135, 2562, 10.4049/jimmunol.135.4.2562 · DOI · Paper page
  10. Gowen, 1983, An interleukin 1 like factor stimulates bone resorption in vitro, Nature, 306, 378, 10.1038/306378a0 · DOI · Paper page
  11. Lorenzo, 1998, Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy, Endocrinology, 139, 3022, 10.1210/endo.139.6.6128 · DOI · Paper page
  12. Kimble, 1995, Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovari-ectomy period, Endocrinology, 136, 3054, 10.1210/endo.136.7.7789332 · DOI · Paper page
  13. Konig, 1988, Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracy-cline excretion from prelabeled mice, J Bone Miner Res, 3, 621, 10.1002/jbmr.5650030607 · DOI
  14. Bertolini, 1986, Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors, Nature, 319, 516, 10.1038/319516a0 · DOI · Paper page
  15. Thomson, 1987, Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption, J Immunol, 138, 775, 10.4049/jimmunol.138.3.775 · DOI · Paper page
  16. Pluijm, 1991, Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix, Endocrinology, 129, 1596, 10.1210/endo-129-3-1596 · DOI
  17. Ishimi, 1990, IL-6 is produced by osteoblasts and induces bone resorption, J Immunol, 145, 3297, 10.4049/jimmunol.145.10.3297 · DOI · Paper page
  18. Jilka, 1992, Increased osteoclast development after estrogen loss: mediation by interleukin-6, Science, 257, 88, 10.1126/science.1621100 · DOI · Paper page
  19. Poli, 1994, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion, Embo J, 13, 1189, 10.1002/j.1460-2075.1994.tb06368.x · DOI · Paper page
  20. Girasole, 1994, Interleukin-11: a new cytokine critical for osteoclast development, J Clin Invest, 93, 1516, 10.1172/JCI117130 · DOI · Paper page
  21. Hill, 1998, The cellular actions of interleukin-11 on bone resorption in vitro, Endocrinology, 139, 1564, 10.1210/endo.139.4.5946 · doi:10.1210/endo.139.4.5946
  22. Ogata, 1999, A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2, J Immunol, 162, 2754, 10.4049/jimmunol.162.5.2754 · DOI
  23. Kotake, 1999, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J Clin Invest, 103, 1345, 10.1172/JCI5703 · DOI · Paper page
  24. Goldring, 2002, Pathogenesis of bone erosions in rheumatoid arthritis, CurrOpin Rheumatol, 14, 406
  25. Bartold, 2005, Periodontitis and rheumatoid arthritis: a review, J Periodontol, 76, 2066, 10.1902/jop.2005.76.11-S.2066 · DOI · Paper page
  26. Anderson KC Shaughnessy JD , Jr. Barlogie B Ha-rousseau JL Roodman GD. Multiple myeloma. He-matology Am Soc Hematol Educ Program 2002 214 240 · DOI
  27. Mundy, 1974, Evidence for the secretion of an osteoclast stimulating factor in myeloma, N Engl J Med, 291, 1041, 10.1056/NEJM197411142912001 · DOI · Paper page
  28. Yeh, 2006, Treatment for myeloma bone disease, Clin Cancer Res, 12, 6279, 10.1158/1078-0432.CCR-06-0681 · DOI
  29. Pacifici, 1991, Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells, Proc Natl Acad Sci USA, 88, 5134, 10.1073/pnas.88.12.5134 · DOI · Paper page
  30. Ammann, 1997, Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency, J Clin Invest, 99, 1699, 10.1172/JCI119333 · DOI · Paper page
  31. Wong, 2005, Phenotypic differences in genetically identical organisms: the epigenetic perspective, Hum Mol Genet, 14, R11, 10.1093/hmg/ddi116 · DOI · Paper page
  32. Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci USA, 95, 3597, 10.1073/pnas.95.7.3597 · DOI · Paper page
  33. Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X · DOI · Paper page
  34. Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, 390, 175, 10.1038/36593 · DOI · Paper page
  35. Fuller, 1998, TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts, J Exp Med, 188, 997, 10.1084/jem.188.5.997 · DOI · Paper page
  36. Roux, 2000, Bone loss. Factors that regulate osteoclast differentiation: an update, Arthritis Res, 2, 451, 10.1186/ar127 · DOI · Paper page
  37. Tanaka, 2005, Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system, Immunol Rev, 208, 30, 10.1111/j.0105-2896.2005.00327.x · DOI · Paper page
  38. Udagawa, 1990, Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells, Proc Natl Acad Sci USA, 87, 7260, 10.1073/pnas.87.18.7260 · DOI · Paper page
  39. Srivastava, 2001, Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation, J Biol Chem, 276, 8836, 10.1074/jbc.M010764200 · DOI · Paper page
  40. Nicklin, 2000, Arterial inflammation in mice lacking the inter-leukin 1 receptor antagonist gene, J Exp Med, 191, 303, 10.1084/jem.191.2.303 · DOI · Paper page
  41. Bucay, 1998, osteoprote-gerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev, 12, 1260, 10.1101/gad.12.9.1260 · DOI · Paper page
  42. Chen, 2006, Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context, Hum Mol Genet, 15, 519, 10.1093/hmg/ddi469 · DOI · Paper page
  43. Dougall, 2006, The RANK/RANKL/OPG triad in cancer-induced bone diseases, Cancer Metastasis Rev, 25, 541, 10.1007/s10555-006-9021-3 · DOI · Paper page

Cited by

See all 478

Metadata

Authors
Mundy, G. R.
Venue
Nutrition Reviews
Published
2008-06-28
Volume
65
Issue
12 Pt 2
Pages
S147-S151
ISSN
0029-6643 (ISSN-L)
OpenAlex
W1991762596
Cited by
478
References
11
FWCI
9.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Osteoporosis and Inflammation. https://app.cochat.ai/papers/10.1111/j.1753-4887.2007.tb00353.x
The paper
Mundy, G. R. (2008). Osteoporosis and Inflammation. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.2007.tb00353.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.